Skip to main content
Erschienen in: Virchows Archiv 4/2013

01.04.2013 | Original Article

Diagnostic utility of aP2/FABP4 expression in soft tissue tumours

verfasst von: T. G. Kashima, H. Turley, A. Dongre, F. Pezzella, N. A. Athanasou

Erschienen in: Virchows Archiv | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Adipocyte P2 (aP2), also known as fatty acid-binding protein 4 (FABP4), is a fatty acid-binding protein found in the cytoplasm of cells of adipocyte differentiation. In this study, we examined a large number of soft tissue tumours with a commercial polyclonal anti-aP2/FABP4 antibody and a newly developed mouse monoclonal antibody raised against this protein to determine the diagnostic utility of aP2/FABP4 as a marker of tumours of adipose differentiation. A mouse monoclonal antibody, clone 175d, was raised against a mixture of synthetic peptides corresponding to the amino acid sequence of residues 10–28 and 121–132 of the human aP2/FABP4 protein. Antigen expression with polyclonal and monoclonal antibodies was immunohistochemically determined in paraffin sections of normal adipose tissue and a wide range of benign and malignant primary soft tissue tumours (n = 200). aP2/FABP4 was expressed around the cytoplasmic lipid vacuole in white and brown fat cells in benign lipomas and hibernomas. Immature fat cells and lipoblasts in spindle cell/pleomorphic lipoma, atypical lipomatous tumour/well-differentiated liposarcoma, myxoid/round cell liposarcoma and pleomorphic liposarcoma also reacted strongly for aP2/FABP4. No specific staining was seen in non-adipose benign and malignant mesenchymal and non-mesenchymal tumours. aP2/FABP4 is expressed by mature and immature fat cells and is a marker of tumours of adipose differentiation. Immunophenotypic aP2/FABP4 expression is useful in identifying lipoblasts, and immunohistochemistry with polyclonal/monoclonal anti-aP2/FABP4 antibodies should be useful in distinguishing liposarcoma from other malignancies, particularly round cell, myxoid and pleomorphic soft tissue sarcomas.
Literatur
1.
Zurück zum Zitat Ailhaud G, Amri E, Barbaras R, Casteilla L, Catolioto R, Dani C (1987) Adipose cell differentiation: differential expression of specific mRNAs and protein markers in cells from white and brown adipose tissues. In: EM B, SH B, HE E, E S (eds) Recent advances in obesity research. John Libbey, Paris, pp. 174–180 Ailhaud G, Amri E, Barbaras R, Casteilla L, Catolioto R, Dani C (1987) Adipose cell differentiation: differential expression of specific mRNAs and protein markers in cells from white and brown adipose tissues. In: EM B, SH B, HE E, E S (eds) Recent advances in obesity research. John Libbey, Paris, pp. 174–180
2.
Zurück zum Zitat Bernlohr DA, Angus CW, Lane MD, Bolanowski MA, Kelly TJ Jr (1984) Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc Natl Acad Sci U S A 81:5468–5472PubMedCrossRef Bernlohr DA, Angus CW, Lane MD, Bolanowski MA, Kelly TJ Jr (1984) Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc Natl Acad Sci U S A 81:5468–5472PubMedCrossRef
3.
Zurück zum Zitat Furuhashi M, Hotamisligil GS (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489–503PubMedCrossRef Furuhashi M, Hotamisligil GS (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489–503PubMedCrossRef
4.
Zurück zum Zitat Yang VW, Christy RJ, Cook JS, Kelly TJ, Lane MD (1989) Mechanism of regulation of the 422(aP2) gene by cAMP during preadipocyte differentiation. Proc Natl Acad Sci U S A 86:3629–3633PubMedCrossRef Yang VW, Christy RJ, Cook JS, Kelly TJ, Lane MD (1989) Mechanism of regulation of the 422(aP2) gene by cAMP during preadipocyte differentiation. Proc Natl Acad Sci U S A 86:3629–3633PubMedCrossRef
5.
Zurück zum Zitat Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (2013) WHO Classification of tumours of soft tissue and bone. IARC Press, Lyon Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F (2013) WHO Classification of tumours of soft tissue and bone. IARC Press, Lyon
6.
Zurück zum Zitat Enzinger FM, Weiss SW (2008) Soft tissue tumours. Mosby, St Louis Enzinger FM, Weiss SW (2008) Soft tissue tumours. Mosby, St Louis
7.
Zurück zum Zitat Miettinen M (2010) Modern soft tissue pathology: tumours and non-neoplastic conditions. Cambridge University Press, Cambridge, pp 60–62CrossRef Miettinen M (2010) Modern soft tissue pathology: tumours and non-neoplastic conditions. Cambridge University Press, Cambridge, pp 60–62CrossRef
8.
Zurück zum Zitat Nakajima T, Watanabe S, Sato Y, Kameya T, Hirota T, Shimosato Y (1982) An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol 6:715–27PubMedCrossRef Nakajima T, Watanabe S, Sato Y, Kameya T, Hirota T, Shimosato Y (1982) An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol 6:715–27PubMedCrossRef
9.
Zurück zum Zitat Bennett JH, Shousha S, Puddle B, Athanasou NA (1995) Immunohistochemical identification of tumours of adipocytic differentiation using an antibody to aP2 protein. J Clin Pathol 48:950–954PubMedCrossRef Bennett JH, Shousha S, Puddle B, Athanasou NA (1995) Immunohistochemical identification of tumours of adipocytic differentiation using an antibody to aP2 protein. J Clin Pathol 48:950–954PubMedCrossRef
10.
Zurück zum Zitat Joyner CJ, Triffitt J, Puddle B, Athanasou NA (1999) Development of a monoclonal antibody to the aP2 protein to identify adipocyte precursors in tumours of adipose differentiation. Pathol Res Pract 195:461–466PubMedCrossRef Joyner CJ, Triffitt J, Puddle B, Athanasou NA (1999) Development of a monoclonal antibody to the aP2 protein to identify adipocyte precursors in tumours of adipose differentiation. Pathol Res Pract 195:461–466PubMedCrossRef
11.
Zurück zum Zitat Galfre G, Milstein C (1981) Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 73:3–46PubMedCrossRef Galfre G, Milstein C (1981) Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol 73:3–46PubMedCrossRef
12.
Zurück zum Zitat Sternberger LA (1986) Immunocytochemistry, 3rd edn. Wiley, New York, pp 164–165 Sternberger LA (1986) Immunocytochemistry, 3rd edn. Wiley, New York, pp 164–165
13.
Zurück zum Zitat Baird K, Davis S, Antonescu CR, Harper UL, Walker RL, Chen Y, Glatfelter AA, Duray PH, Meltzer PS (2005) Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res 65:9226–9235PubMedCrossRef Baird K, Davis S, Antonescu CR, Harper UL, Walker RL, Chen Y, Glatfelter AA, Duray PH, Meltzer PS (2005) Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res 65:9226–9235PubMedCrossRef
14.
Zurück zum Zitat Matushansky I, Hernando E, Socci ND, Matos T, Mills J, Edgar MA, Schwartz GK, Singer S, Cordon-Cardo C, Maki RG (2008) A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas. Am J Pathol 172:1069–1080PubMedCrossRef Matushansky I, Hernando E, Socci ND, Matos T, Mills J, Edgar MA, Schwartz GK, Singer S, Cordon-Cardo C, Maki RG (2008) A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas. Am J Pathol 172:1069–1080PubMedCrossRef
15.
Zurück zum Zitat Kato K, Suzuki F, Ogasawara N (1988) Induction of S100 protein in 3 T3-L1 cells during differentiation to adipocytes and its liberating by lipolytic hormones. Eur J Biochem 1(177):461–6CrossRef Kato K, Suzuki F, Ogasawara N (1988) Induction of S100 protein in 3 T3-L1 cells during differentiation to adipocytes and its liberating by lipolytic hormones. Eur J Biochem 1(177):461–6CrossRef
16.
Zurück zum Zitat Graadt van Roggen JF, Hogendoorn PCW, Fletcher CD (1999) Myxoid tumours of soft tissue. Histopathology 35:291–312PubMedCrossRef Graadt van Roggen JF, Hogendoorn PCW, Fletcher CD (1999) Myxoid tumours of soft tissue. Histopathology 35:291–312PubMedCrossRef
17.
Zurück zum Zitat White UA, Stephens JM (2010) Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol 318:10–14PubMedCrossRef White UA, Stephens JM (2010) Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol 318:10–14PubMedCrossRef
18.
Zurück zum Zitat Ntambi JM, Young-Cheul K (2000) Adipocyte differentiation and gene expression. J Nutr 130:3122S–3126SPubMed Ntambi JM, Young-Cheul K (2000) Adipocyte differentiation and gene expression. J Nutr 130:3122S–3126SPubMed
19.
Zurück zum Zitat Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H, Hotamisligil GS (2008) Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 118:2640–2650PubMed Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H, Hotamisligil GS (2008) Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 118:2640–2650PubMed
20.
Zurück zum Zitat Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, Kozakewich H, Bischoff J, Cataltepe S (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23:3865–3873PubMedCrossRef Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, Ince TA, Kozakewich H, Bischoff J, Cataltepe S (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23:3865–3873PubMedCrossRef
Metadaten
Titel
Diagnostic utility of aP2/FABP4 expression in soft tissue tumours
verfasst von
T. G. Kashima
H. Turley
A. Dongre
F. Pezzella
N. A. Athanasou
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 4/2013
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-013-1392-6

Weitere Artikel der Ausgabe 4/2013

Virchows Archiv 4/2013 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …